Lifeboat Foundation

:333 this could be used for coronavirus: 3.

Microfluidic devices lined with living human cells for drug development, disease modeling, and personalized medicine.

A new approach would use RNA or DNA to help the body develop antibodies to the rapidly spreading illness.

A U.S. military research program that seeks a new way to boost a body’s immunity to viruses could change how governments and militaries prepare for pandemics — and might even arrive soon enough to help with the COVID −19 outbreak.

DARPAs Pandemic Prevention Platform isn’t looking to create a vaccine, which can take years to produce and weeks to take effect in the body. Rather, the goal is to identify the specific monoclonal antibodies that the body naturally produces when it encounters a virus, and then trick the body into producing the one that guards against a specific illness. That could serve as a temporary, months-long shield that can protect the individual from the pathogen until a vaccine can be brought online.

North Korea conducted its sixth nuclear test on 3 September 2017, stating it had tested a thermonuclear weapon (hydrogen bomb).^[6].

And others in the research community, like this nuclear physicist at the Large Hadron Collider, are realizing how close they came to catching the virus.

The first COVID-19 case may have started as early as November 17. A good chunk of my reararch group, and our particular slice of the nuclear physics community, were literally in Wuhan until just a week before this. To think what could have been… https://www.scmp.com/news/china/society/article/3074991/coro…raced-back

— Dennis V. Perepelitsa (@dvperepelitsa) March 13, 2020

Coronavirus Research : A recent study published on an open platform but has yet to be peer reviewed caught our eyes as it was strangely conducted by the prestigious Spiez Laboratory In Switzerland by a team of leading virologists and microbiologists, but what intrigued me was that why would a prestigious research centre like the Spiez laboratory that had enormous funds and had some of the leading specialist post a ‘half-baked’ research on an open platform?

Echinacea Flowers

With commercial satellite technology, Toyota showed it can create HD maps more quickly and do it in a cost-effective manner.

Scientists have struggled to develop new antibiotics. Enter: the machines.

Turkey’s first electromagnetic anti-drone systems manufacturer Harp Arge (R&D) on Sunday unveiled its 2.5-kilogram (5.5-pound) anti-drone weapon produced with the latest antenna technology, allowing for reduced size and weight.

The technology firm, which has been working to improve capabilities of national drone systems, introduced its newest product, ES-60 Electromagnetic Anti Drone Gun, designed to inflict high-speed electromagnetic interference to disrupt communications between drones and their control units and cause enemy devices to malfunction.

The Harp Arge said the anti-drone gun has a weight of 2.5 kilograms and is capable of combating rogue drones within a 3-kilometer (1.86-mile) range. The company said the new antenna technology installed enabled the company to reduce the size and weight of the weapon to an impressive extent. The firm added that the jamming weapon is produced using more than 70% of locally sourced content and would only be provided to government agencies as per weapons regulations.

Although the majority of the synthetic biology market is concentrated in North America and Europe, the synthetic biology landscape is growing worldwide — with some of the fastest growing areas developing outside of the United States. There are several hotspots — formed when innovation at one company or university lab sparks new spinoffs — that synthetic biology followers should pay close attention to in the coming months and years.

The United Kingdom and Ireland

Among non-US hotspots for synthetic biology, the United Kingdom stands out. While most US universities still lack programs in synthetic biology, they are not hard to come by in the UK. Imperial College London, the University of Warwick, Cambridge University, and the University of Edinburgh are all particularly noteworthy for the depth and breadth of synthetic biology research. And, OpenPlant, a joint initiative between the University of Cambridge, John Innes Centre, and the Earlham Institute, is advancing synthetic biology by engineering the next generation of DNA tools for “smart” crop breeding systems.